Back
Avicanna, Inc. 10K Form
Sell
28
AVCN.TO
Avicanna, Inc.
Last Price:
$0.23
Seasonality Move:
-24.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AVCN.TO News And Ratings
See the #1 stock for the next 7 days that we like better than AVCN.TO
AVCN.TO Financial Statistics
Sales & Book Value
| Annual Sales: | $25.5M |
|---|---|
| Cash Flow: | $-865.2K |
| Price / Cash Flow: | 177.56 |
| Annual Sales: | $0.03 |
| Price / Book: | 8.71 |
Profitability
| EPS (TTM): | -0.01640 |
|---|---|
| Net Income (TTM): | $-1.9M |
| Gross Margin: | $12.8M |
| Return on Equity: | -17.95% |
| Return on Assets: | -9.12% |
Avicanna, Inc. Earnings Forecast
Key Avicanna, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for AVCN.TO is 50.13%.
-
The Selling, General & Administrative Expenses for AVCN.TO have been equal to 57.62% of Gross Profit Margin.
-
The Research & Development expenses have been 0.70% of Revenue.
-
The Net Earning history of AVCN.TO is -14.21% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
Avicanna, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSX |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AVCN.TO |
| Website: | avicanna.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.9 |
| Quick Ratio: | 0.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AVCN.TO Technical Analysis vs Fundamental Analysis
Sell
28
Avicanna, Inc. (AVCN.TO)
is a Sell
Is Avicanna, Inc. a Buy or a Sell?
-
Avicanna, Inc. stock is rated a SellThe current Avicanna, Inc. [AVCN.TO] share price is $0.23. The Score for AVCN.TO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.